Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice da

Recall map → All recalls → F-1756-2018

Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case Seroyal International, a division of Atrium Innovations · reported 2018-08-15

Terminated This recall has been closed out by the agency.

Reason for recall: Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Classification: Class II
Recall initiated: 2018-07-27
Reported by the agency: 2018-08-15
Closed out (terminated): 2020-11-25
Recalling firm: Seroyal International, a division of Atrium Innovations
Richmond Hill, Ontario
Canada
This is the firm that issued the recall — commonly a distributor or processor. It is not the origin of contamination.
Distribution (the agency's own words): Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees).
States we parsed from that text: could not be parsed
No state list could be read from the agency's text. Absence here is not evidence the product stayed put.
Food category: Dietary supplementsderived
Assigned by a reviewed keyword rulebook over the product description, not by the agency.
Recall type: Voluntary: Firm initiated
Recall number: F-1756-2018

This page reproduces a record published by the US Food and Drug Administration. It is not real-time: recalls typically appear in FDA's Enforcement Report weeks after they begin — a median of 40 days, see publication lag. For current food safety information consult FDA and USDA FSIS directly.